Condition: Intervertebral Disc Degeneration · Sponsor: SPINEVISION SAS
The goal of this observational study is to confirm the safety and efficacy of the Hexanium TLIF system in the treatment of skeletally mature patients suffering from degenerative disc disease (disease that occurs when the spinal disk break down). Part of their standard of care, participants will be questioned on their back and leg pains, their disability and if they have encountered any adverse effects since the Hexanium TLIF system implant surgery. Those data will be collected up to twenty four (24) months after the Hexanium TLIF system implant surgery.
This description comes directly from the study's public registry record.
Renaud Duchenes · +33 6 86 16 61 91 · r.duchenes@spinevision.com
Hanta Ranaivoson · h.ranaivoson@spinevision.com
Always discuss trial participation with your own doctor first.
| Clinique du dos Terrefort | Bruges, France | Recruiting |
| Clinique Saint Charles | Lyon, France | Recruiting |
| Hopital privé Clairval | Marseille, France | Recruiting |
| CHRU Nancy | Nancy, France | Recruiting |
| Polyclinique Majorelle | Nancy, France | Recruiting |
| Clinicque Générale Beaulieu | Geneva, Switzerland | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05997121